The three stocks we are going to discuss today come from one of the hottest sectors.
This sector has made headlines since April as the coronavirus came into focus outside of China.
Now, the biotech sector is all the rage as companies scramble to find a suitable vaccine.
The S&P Biotech SPDR ETF (NYSEARCA: XBI) — an exchange-traded fund (ETF) tracking some of the biggest biotech stocks — jumped more than 79% since reaching a low in March 2020.
It topped out at around $120 per share in July and has only pulled back slightly since.
In this episode of The Bull & The Bear, I’ll talk with Money & Markets Chief Investment Strategist Adam O’Dell and contributor Charles Sizemore about three biotech stocks.
We’ll examine what each of these three companies do and how they’ve performed recently.
Be sure to also subscribe to our YouTube channel for more videos and information.
Have something you want us to talk about? Email us at firstname.lastname@example.org and give us your thoughts.
Check out moneyandmarkets.com and sign up for our free newsletters that deliver you the most important and unbiased financial news, commentary and actionable advice.
Also, follow us on: